GoodRx reports that while satisfaction with GLP-1s for weight loss is high, costs and access issues significantly impact patient experiences.
GoodRx reports that step therapy requires patients to try lower-cost medications before coverage for prescribed treatments.
The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.
Kivo reports that the journey of prescription drugs involves extensive research, clinical trials, regulatory reviews, and global supply chains.
The reasons are not fully understood, but changes in the gut microbiome are believed to play a role.
FRANKLIN — Rep. Maggie Goodlander (CD2), during a roundtable discussion at HealthFirst Family Care Center on Tuesday, spoke to health care lea…
LACONIA — At the intersection of Union and Gilford Avenues, for many years, medical patients filled their prescriptions at the Rite Aid pharma…